Raymond James & Associates CAESARS ENTMT CORP Transaction History

Raymond James & Associates

$161 Billion
Q3 2024

Shares

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2020 Nov 04, 2020	SELL	N/A	-128,242 Closed	0 $0
Q2 2020 Jul 28, 2020	BUY	N/A	29,787 Added 30.25%	128,242 $1.56 Million
Q1 2020 Apr 21, 2020	SELL	N/A	-19,246 Reduced 16.35%	98,455 $666,000
Q4 2019 Feb 12, 2020	SELL	N/A	-13,616 Reduced 10.37%	117,701 $1.6 Million
Q3 2019 Nov 07, 2019	SELL	N/A	-19,467 Reduced 12.91%	131,317 $1.53 Million
Q2 2019 Aug 06, 2019	SELL	N/A	-118,119 Reduced 43.93%	150,784 $1.78 Million
Q1 2019 May 06, 2019	BUY	N/A	172,161 Added 177.96%	268,903 $2.34 Million
Q4 2018 Feb 11, 2019	SELL	N/A	-332,498 Reduced 77.46%	96,742 $657,000
Q3 2018 Nov 14, 2018	BUY	N/A	156,800 Added 57.55%	429,240 $4.4 Million
Q2 2018 Aug 14, 2018	BUY	N/A	41,268 Added 17.85%	272,440 $2.92 Million
Q1 2018 May 14, 2018	BUY	N/A	91,845 Added 65.92%	231,172 $2.6 Million
Q4 2017 Feb 14, 2018	BUY	N/A	30,812 Added 28.39%	139,327 $1.76 Million
Q3 2017 Nov 13, 2017	BUY	N/A	10,000 Added 10.15%	108,515 $1.45 Million
Q2 2017 Aug 14, 2017	BUY	N/A	98,515	98,515 $1.18 Million

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.